Nymox Pharmaceutical Corporation (NYMX) analyst actions
Rating and price-target actions on NYMX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NYMX overview →
No NYMX analyst action events in the measured window.
Nothing matched in the current window — the NYMX overview has every event we measure for this name.
Get an email when NYMX moves on news →Keep exploring
More NYMX: earnings → · SEC filings → · NYMX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cytocom Inc. (CBLI) | 434 | 0.00% | 40% |
| Charles River Laboratories International, Inc. (CRL) | 434 | -0.10% | 45% |
| IMMUNE DESIGN CORP COMMON STOCK (IMDZ) | 432 | -0.12% | 43% |
| CRH MEDICAL CORP (CRHM) | 431 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.